Tucson Myofilament Meeting, May 23-26

The Tucson Myofilament Meeting is an international 3.5-day Sarver Heart Center conference that brings together approximately 250 scientists focused on the structure and function of the myofilaments that comprise the contractile machinery of muscle. Spanning topics from molecular biophysics to heart and skeletal muscle disease mechanisms and drug development, the meeting is known for its highly interactive, collaborative, and informal atmosphere, with strong engagement of early career investigators.

Traditionally held biennially at the University of Wisconsin, the meeting will continue at the University of Arizona beginning in May 2026, offering a distinctive Tucson setting that fosters scientific exchange and community building.

Learn More and Register

IMB Research Seminar with TGen’s John Altin, PhD

Friday, January 18, 2019 - 12:00pm
Event Location: 

Medical Research Building, Room 102
University of Arizona Health Sciences Campus
1656 E. Mabel St.
Tucson, AZ 85721

The University of Arizona Department of Immunobiology presents:

TITLE: “Next-Generation Tools Enabling Systems Analysis of Adaptive Immunity”
SPEAKER: John Altin, PhD | Assistant Professor, Translational Genomics Research Institute (T-Gen), Flagstaff, Ariz.

Friday, Jan. 18, 2019
Noon
Medical Research Building, Room 102

About the Speaker:
Dr. John Altin is an Assistant Professor who works jointly across the Pathogen Genomics and Integrated Cancer Genomics Divisions at TGen. His research interests lie at the intersection of T cell immunology and genomics, where he studies the human T cell response in the context of both pathogens and tumors — two settings where an ability to reliably invoke a successful immune response holds great promise for public health. He began his research career in the Immunogenomics lab of Chris Goodnow where he used genome-wide mouse mutagenesis and cellular immunology techniques to reveal new pathways of T cell regulation (Altin et al 2011, Altin et al 2012, Altin et al 2014). After graduating in 2012, he joined Prognosys Biosciences, a start-up biotech company founded by Mark Chee in San Diego that develops novel, highly-parallel tools for proteomics. John applied this technology to the adaptive immune system, developing new assays to view T and B lymphocyte responses at high-resolution (US2016-0291007-A1, US2016-0025726-A1). Building on this training in cellular immunology and highly-multiplexed genomic assay development, John is now working to generate a systems-level understanding of human T cell immunity, which he hopes can lay the groundwork for new approaches to the diagnosis and treatment of cancers and pathogen-mediated disease.

Questions? Contact the Department of Immunobiology, (520) 626-6409, email or web

Seminar Flyer (please, view, post and share with colleagues):
 2019-01-15 Dr. Bothwell - Seminar Flyer (1).pdf